Editorial

Renata Mikołajczak, Grzegorz Kamiński

HTML

99mTc-EDDA/HYNIC-TOC in the diagnosis of differentiated thyroid carcinoma refractory to radioiodine treatment

Rafał Czepczyński, Maria Gryczyńska, Marek Ruchała

Research paper

PDF HTML

99mTc-EDDA/HYNIC-TOC in management of patients with head and neck somatostatin receptor positive tumors

Mate Trogrlic, Stanko Tezak

Research paper

PDF HTML

Clinical application of SPECT-CT with 99mTc-Tektrotyd in bronchial and thymic neuroendocrine tumors (NETs)

Sonya Sergieva, Bozhil Robev, Milena Dimcheva, Albena Fakirova, Radka Hristoskova

Research paper

PDF HTML

Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT

Dorota Madrzak, Renata Mikołajczak, Grzegorz Kamiński

Research paper

PDF HTML

Limitations and pitfalls of 99mTc-EDDA/HYNIC-TOC (Tektrotyd) scintigraphy

Ildikó Garai, Sandor Barna, Gabor Nagy, Attila Forgacs

Research paper

PDF HTML

Evaluation of neuroendocrine tumors with 99mTc-EDDA/HYNIC TOC

Vera Artiko, Aida Afgan, Jelena Petrović, Branislava Radović, Nebojša Petrović, Marina Vlajković, Dragana Šobić-Šaranović, Vladimir Obradović

Research paper

PDF HTML

Oxidation of methionine — is it limiting the diagnostic properties of 99mTc-labeled Exendin-4, a Glucagon-Like Peptide-1 receptor agonist?

Barbara Janota, Urszula Karczmarczyk, Ewa Laszuk, Piotr Garnuszek, Renata Mikołajczak

Research paper

PDF HTML

Neuroendocrine neoplasms and somatostatin receptor subtypes expression

Jerzy Hankus, Romana Tomaszewska

Review paper

PDF HTML

NEN — the role of somatostatin receptor scintigraphy in clinical setting

Marta Opalińska, Alicja Hubalewska-Dydejczyk, Anna Sowa-Staszczak, Agnieszka Stefańska

Review paper

PDF HTML

Radiopharmaceuticals for somatostatin receptor imaging

Renata Mikołajczak, Helmut R. Maecke

Review paper

PDF HTML

Calendar of Events 2016

Agnieszka Krajewska

Other materials agreed with the Editors

HTML